It was concluded that CD28/CD80 is crucial in promoting T cell inflammation in psoriasis and the effect of blocking CD28/CD80 signalling by CTLA-4 analogues or by anti-CD28 blocking antibodies is effective against PsA. The gene discussed is CD80; the disease is psoriasis.